Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ACT-385781A (Actelion Epoprostenol)
(D00106)		1件: Epoprostenol1件: Epoprostenol (D00106) 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2Current marketed FLOLAN (epoprostenol sodium)
(D00106)		1件: Epoprostenol1件: Epoprostenol (D00106) 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
3EPOPROSTENOL
(D00106)		1件: Epoprostenol1件: Epoprostenol (D00106) 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4Epoprostenol for injection
(D00106)		1件: Epoprostenol1件: Epoprostenol (D00106) 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
5EPOPROSTENOL SODICO
(D00106)		1件: Epoprostenol1件: Epoprostenol (D00106) 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6EPOPROSTENOL SODIUM
(D00106)		1件: Epoprostenol1件: Epoprostenol (D00106) 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
7Epoprostenol-Actelion
(D00106)		1件: Epoprostenol1件: Epoprostenol (D00106) 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
8New thermo stable formulation of epoprostenol sodium
(D00106)		1件: Epoprostenol1件: Epoprostenol (D00106) 💬1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬